about
In vitro studies of nanosilver-doped titanium implants for oral and maxillofacial surgery.Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods[Estimation of activity of pharmakopeal disinfectants and antiseptics against Gram-negative and Gram-positive bacteria isolated from clinical specimens, drugs and environment].Modification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon.Non-antibiotics--drugs with additional antimicrobial activity.The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods.Activity of ozonated water and ozone against Staphylococcus aureus and Pseudomonas aeruginosa biofilmsAntibacterial activity of selected commercial products for mouth washing and disinfection, assessed in accordance with PN-EN 1040.Evaluation of mycobactericidal activity of selected chemical disinfectants and antiseptics according to European standards.Recent development of potent analogues of oxazolidinone antibacterial agents.Looking for the new preparations for antibacterial therapy III. New antimicrobial agents from the quinolones group in clinical trials.Looking for the new preparations for antibacterial therapy. V. New antimicrobial agents from the oxazolidinones groups in clinical trialsIdentification and determination of related substances of ceftaroline fosamil in medicinal product by high performance liquid chromatography with diode array detection and tandem mass spectrometry.Activity of Natural Polyether Ionophores: Monensin and Salinomycin against Clinical Staphylococcus epidermidis Strains.Looking for new preparations for antibacterial therapy. IV. New antimicrobial agents from the aminoglycoside, macrolide and tetracycline groups in clinical trials.Molecular and phenotypic characteristics of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in transplantation wards.[Genetic similarity of vancomycin resistant strains of Enterococcus faecium isolated from clinical specimens].[Evaluation of biofilm formation by Staphylococcus aureus isolated from sputum of cystic fibrosis patients].[Analysis of Pseudomonas aeruginosa biofilm production in relation to cultivation media and biofilm staining methods].[The estimation of penetrating of microbes by the protective clothing and textile medical devices, according to obligatory norms].CE versus LC for simultaneous determination of amoxicillin/clavulanic acid and ampicillin/sulbactam in pharmaceutical formulations for injections.Biological evaluation of quaternary bis ammonium salt and cetylpyridinum bromide against S. epidermidis biofilm.Application of micellar electrokinetic chromatography to the determination of sultamicillin in oral pharmaceutical preparations.Search of antimicrobial activity of selected non-antibiotic drugs.Application of MEKC for determination of ticarcillin and clavulanic acid in Timentin intravenous preparation.Capillary electrophoresis method for simultaneous determination of penicillin G, procaine and dihydrostreptomycin in veterinary drugs.Application of capillary electrophoresis to the determination of various benzylpenicillin salts.[Interaction of neomycin with other antibiotics on selected bacterial strains].[Evaluation of selected alcoholic antiseptics activity against clinical bacterial strains].[Evaluation of biocidal properties of silver nanoparticles against cariogenic bacteria].[Interaction of aminoglycosides and the other antibiotic on selected bacterial strains].The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.Antimicrobial activity of 2,4-dihydro-[1,2,4]triazol-3-one derivatives.Examination of antimicrobial activity of selected non-antibiotic drugs.[Comparison of checkerboard and time-kill methods for the analysis of two antibiotics combined].Determination of linezolid and its achiral impurities using sweeping preconcentration by micellar capillary electrophoresis.Determination of enantiomeric impurity of linezolid by capillary electrophoresis using heptakis-(2,3-diacetyl-6-sulfato)-beta-cyclodextrin.Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.Evidence for tetracycline resistance determinant tet(M) allele replacement in a Streptococcus pneumoniae population of limited geographical origin.Oral microbiome and peri-implant diseases: where are we now?
P50
Q33807168-2BB1104A-34E5-4E70-90D4-36D65D64AB62Q33848456-D52EB996-0C36-49E5-9EC5-BA104AF812EBQ34580708-B81E55A4-492A-4A7D-A613-BF933063445EQ35203279-19DC7AD7-F668-422A-BF8F-2766BD44B14AQ35684246-8F4A901C-3D85-4974-8025-8585FB3DFE5AQ35895154-085526E5-7186-40EE-B70E-03E8E5382337Q36516253-903EE46E-7807-4F4C-8FA7-E29233798ED4Q36954694-6C060F9E-5BDD-4321-8BEB-DAA0D054C5D5Q37734677-3EE1894C-8D0A-415D-AA48-272B37F19FFEQ38070222-881FBEB8-245F-466C-94AD-EAE833EC4B1EQ39294415-36BE3539-0635-40C6-9F4E-1CA36A12EEE5Q40066743-CAA862C0-D238-4557-B462-06E8D6B1D6A8Q40097017-8166DF69-2D6B-4F17-B329-2DC895F5E115Q40882212-B61F3380-4C2B-443B-8711-3AE6BF851407Q41574258-F431FCF9-29C7-42A8-A28B-548F4A954A6BQ41671284-628927B5-D345-41A4-868F-E2091098D962Q42743695-BE249CD9-9869-4DA4-8E5F-09FB811B1CFFQ43011353-4BEA7DC7-BCEF-40FA-A076-854DF5BEC6D8Q43178766-45BBD7F8-4D0C-4B69-BFF6-C38CDD0AD7F0Q43626129-4DC566E9-47A5-4DA7-89AD-B095B43C716FQ44026383-18204327-3C9A-4772-A331-F887DBE991C5Q44185565-AECD9F02-B5A7-4428-97B0-A3B3EE070B9AQ44259724-64A7DC20-B5A4-42C9-8AFB-460B0E574688Q44386322-8353A6A1-9146-400A-8BD0-634DE71F1CDFQ44507617-5954E78C-CBA3-4C6C-8AFE-3644E7DEF33AQ44708198-C7B30135-877A-4CF8-A0A2-5D09C99A036CQ44831346-46F62CB5-8880-4F97-A6AE-3B49C81AADFDQ45150851-71B71309-AB56-48F5-BB6C-B9D2678B45F8Q45150854-1C8EFE35-EF47-4F52-B753-BFF422281437Q45742189-CE68FCF0-D1ED-4FC2-A51E-25067C8D12E1Q46386095-9AD0232F-4DD9-4B3B-9A51-9F5EC90E70ACQ46432988-849A13CE-26EE-48B7-91CB-8CB042B683D5Q46469681-22C443CB-B7FA-4F12-B102-6B83EF9C496FQ46503935-A1C189D4-D9E9-4110-8942-63373767CFCFQ46549928-48629737-01AC-4534-9D00-F5EF8E30287FQ46737239-A81680C5-E8C7-46B1-BBD0-54A5557ED47BQ46829617-C5B51FC6-F217-49F0-9354-7F7023B7490AQ46894235-BF8F2EF8-7B05-4E6A-922D-A958ECDC4AA0Q46901645-988AF27A-9658-42B4-A414-ED876469000AQ47100096-3BAB6FC9-4A92-4580-AA4C-B3F5ED1A8E13
P50
description
Polish pharmacologist
@en
Pools onderzoeker
@nl
cógaseolaí Polannach
@ga
polski farmakolog
@pl
name
Stefan Tyski
@ast
Stefan Tyski
@ca
Stefan Tyski
@de
Stefan Tyski
@en
Stefan Tyski
@es
Stefan Tyski
@fr
Stefan Tyski
@ga
Stefan Tyski
@gl
Stefan Tyski
@it
Stefan Tyski
@nl
type
label
Stefan Tyski
@ast
Stefan Tyski
@ca
Stefan Tyski
@de
Stefan Tyski
@en
Stefan Tyski
@es
Stefan Tyski
@fr
Stefan Tyski
@ga
Stefan Tyski
@gl
Stefan Tyski
@it
Stefan Tyski
@nl
prefLabel
Stefan Tyski
@ast
Stefan Tyski
@ca
Stefan Tyski
@de
Stefan Tyski
@en
Stefan Tyski
@es
Stefan Tyski
@fr
Stefan Tyski
@ga
Stefan Tyski
@gl
Stefan Tyski
@it
Stefan Tyski
@nl
P214
P1153
56265936300
P1412
P1559
Stefan Tyski
@pl
P21
P214
P27
P31
P3124
P496
0000-0003-3352-038X
P569
1952-03-09T00:00:00Z
P735
P7859
viaf-250365715